@article{07733a7ea23e4ec69941a30f661a4a68,
title = "The Incidence of Febrile Neutropenia (FN) for Chemotherapy Patients Receiving pegfilgrastim by an On-body Injector (pegfilgrastim OBI) versus other FN Prophylaxis Strategies",
abstract = " Jeffrey Crawford ; Robert Rifkin ; David Dale ; Alan Brookhart ; Prasad Gawade ; Tatiana Lawrence ; Rejesh Balani ; Gary H Lyman ",
author = "Reshma Mahtani",
note = "Abstract. For safety reasons, pegfilgrastim should be administered the day after chemotherapy for prophylaxis of chemotherapy-induced FN (Lyman et al, Cancer. 2017;25:2619-2629). Because this is inconvenient, the pegfilgrastim OBI was developed to reliably deliver pegfilgrastim at 27 hours after its application.",
year = "2020",
month = feb,
day = "15",
language = "American English",
volume = "80",
journal = "Cancer Research / San Antonio Breast Cancer Symposium 2020",
}